Abstract

Get full access to this article
View all access options for this article.
References
1.
Frohman
L
. Therapeutic options in acromegaly . J Clin Endocrinol Metab
1991 ; 72 : 1175 –81 .
2.
Christensen
SE
Weeke
J
Orskov
H
Kaal
A
Jorgensen
J
Harris
AG
. Long term efficacy and tolerability of octreotide treatment in acromegaly . Metabolism
1992 ; 41 (suppl 2 ): 44 –50 .
3.
Cohen
R
Chanson
P
Bruckert
E
Timsit
J
Legrand
A
Harris
AG
, Effects of octreotide on lipid metabolism in acromegaly . Horm Metab Res
1992 ; 24 : 397 –400 .
4.
James
RA
Moller
N
Chatterjee
S
White
M
Kendall-Taylor
P
. Carbohydrate tolerance and serum lipids in acromegaly before and during treatment with high dose octreotide . Diabet Med
1991 ; 8 : 517 –23 .
5.
Norgaard
K
Snorgaard
O
Jensen
T
Kirkegaard
C
. Effects of octreotide on lipoproteins and endothelial function of type 1 (insulin dependent) diabetic patients . Diabet Med
1990 ; 7 : 990 –3 .
